• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

直接口服抗凝剂在左心室血栓治疗中的应用：一家三级中心的经验及文献综述

Use of direct oral anticoagulants in the treatment of left ventricular thrombi: A tertiary center experience and review of the literature.

作者信息

Shokr Mohamed, Ahmed Abdelrahman, Abubakar Hossam, Sayedahmad Ziad, Rashed Ahmed, Afonso Luis, Cardozo Shaun

机构信息

Division of Cardiology, Department of Internal Medicine Wayne State University/Detroit Medical Center Detroit Michigan.

Department of Internal Medicine Wayne State university/Detroit Medical Center Detroit Michigan.

出版信息

Clin Case Rep. 2018 Nov 22;7(1):135-142. doi: 10.1002/ccr3.1917. eCollection 2019 Jan.

DOI:10.1002/ccr3.1917
PMID:30656027
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6332814/
Abstract

Direct oral anticoagulants can potentially provide a more convenient oral alternative for the management of left ventricular thrombi than Warfarin. These medications do not require frequent monitoring and have less drug-drug interactions. Randomized controlled trials are needed to further demonstrate their efficacy and safety in this setting.

摘要

与华法林相比，直接口服抗凝剂可能为左心室血栓的治疗提供一种更方便的口服替代方案。这些药物不需要频繁监测，且药物相互作用较少。需要进行随机对照试验以进一步证明它们在此情况下的疗效和安全性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea19/6332814/e60824fb43d0/CCR3-7-135-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea19/6332814/9a74f2d75f3a/CCR3-7-135-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea19/6332814/e60824fb43d0/CCR3-7-135-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea19/6332814/9a74f2d75f3a/CCR3-7-135-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea19/6332814/e60824fb43d0/CCR3-7-135-g002.jpg

相似文献

1
Use of direct oral anticoagulants in the treatment of left ventricular thrombi: A tertiary center experience and review of the literature.直接口服抗凝剂在左心室血栓治疗中的应用：一家三级中心的经验及文献综述
Clin Case Rep. 2018 Nov 22;7(1):135-142. doi: 10.1002/ccr3.1917. eCollection 2019 Jan.
2
Efficacy of direct oral anticoagulants on the resolution of left ventricular thrombus-A case series and literature review.直接口服抗凝剂对左心室血栓溶解的疗效——病例系列及文献综述
JRSM Cardiovasc Dis. 2019 Apr 8;8:2048004019839548. doi: 10.1177/2048004019839548. eCollection 2019 Jan-Dec.
3
Effect of direct oral anticoagulants versus vitamin K antagonists or warfarin in patients with left ventricular thrombus outcomes: A systematic review and meta-analysis.直接口服抗凝剂与维生素K拮抗剂或华法林对左心室血栓患者预后的影响：一项系统评价和荟萃分析。
Rev Port Cardiol. 2023 Jan;42(1):63-70. doi: 10.1016/j.repc.2021.11.013. Epub 2022 Nov 9.
4
Use of Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus: Systematic Review of Current Literature.直接口服抗凝剂在左心室血栓治疗中的应用：当前文献的系统评价。
Am J Ther. 2020 Nov/Dec;27(6):e584-e590. doi: 10.1097/MJT.0000000000000937.
5
Use of Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombi: A Systematic Review.直接口服抗凝剂在左心室血栓治疗中的应用：系统评价。
Am J Med. 2020 Nov;133(11):1266-1273.e6. doi: 10.1016/j.amjmed.2020.05.012. Epub 2020 Jun 19.
6
Efficacy of direct oral anticoagulants on left ventricular thrombus.直接口服抗凝剂对左心室血栓的疗效。
Blood Coagul Fibrinolysis. 2019 Apr;30(3):96-103. doi: 10.1097/MBC.0000000000000801.
7
An Updated Review of the Efficacy and Safety of Direct Oral Anticoagulants in Treatment of Left Ventricular Thrombus.直接口服抗凝剂治疗左心室血栓的疗效和安全性的更新评价。
Am J Med. 2022 Jan;135(1):17-23. doi: 10.1016/j.amjmed.2021.07.023. Epub 2021 Aug 29.
8
Off-label Use for Direct Oral Anticoagulants: Valvular Atrial Fibrillation, Heart Failure, Left Ventricular Thrombus, Superficial Vein Thrombosis, Pulmonary Hypertension-a Systematic Review.直接口服抗凝剂的超适应证应用：瓣膜性心房颤动、心力衰竭、左心室血栓、浅静脉血栓形成、肺动脉高压——系统评价。
Ann Pharmacother. 2021 Aug;55(8):995-1009. doi: 10.1177/1060028020970618. Epub 2020 Nov 4.
9
Efficacy and Safety of Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus After Acute Anterior Myocardial Infarction in Patients Who Underwent Percutaneous Coronary Intervention.直接口服抗凝剂治疗经皮冠状动脉介入治疗后急性前壁心肌梗死患者左心室血栓的疗效和安全性。
Curr Vasc Pharmacol. 2022;20(6):517-526. doi: 10.2174/1570161120666221003104821.
10
Comparative Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Chronic Liver Disease: A Nationwide Cohort Study.直接口服抗凝剂与华法林在伴有慢性肝脏疾病的心房颤动患者中的有效性和安全性的比较：一项全国性队列研究。
Circulation. 2023 Mar 7;147(10):782-794. doi: 10.1161/CIRCULATIONAHA.122.060687. Epub 2023 Feb 10.

引用本文的文献

1
Non-vitamin K oral antagonist (NOAC) compared to vitamin K antagonist (VKA) in left ventricular thrombus.左心室血栓中新型口服抗凝药（NOAC）与维生素K拮抗剂（VKA）的比较
J Family Med Prim Care. 2024 Jun;13(6):2485-2490. doi: 10.4103/jfmpc.jfmpc_1905_23. Epub 2024 Jun 14.
2
Direct Oral Anticoagulants: Navigating Through Clinical Challenges.直接口服抗凝剂：应对临床挑战。
Cardiovasc Drugs Ther. 2024 Jun;38(3):637-650. doi: 10.1007/s10557-023-07499-0. Epub 2023 Aug 8.
3
Case report: Oral anticoagulant combined with percutaneous coronary intervention for peripheral embolization of left ventricular thrombus caused by myocardial infarction in a patient with diabetes mellitus.

本文引用的文献

1
Rivaroxaban for treatment of intraventricular thrombus in Chagas disease.利伐沙班用于治疗恰加斯病的脑室内血栓。
J Cardiol Cases. 2015 Dec 8;13(3):75-77. doi: 10.1016/j.jccase.2015.10.010. eCollection 2016 Mar.
2
Left Ventricular Thrombus After Acute Myocardial Infarction: Screening, Prevention, and Treatment.急性心肌梗死后左心室血栓：筛查、预防和治疗。
JAMA Cardiol. 2018 Jul 1;3(7):642-649. doi: 10.1001/jamacardio.2018.1086.
3
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.
病例报告：口服抗凝药联合经皮冠状动脉介入治疗糖尿病患者心肌梗死所致左心室血栓外周栓塞
Front Cardiovasc Med. 2022 Dec 8;9:1019945. doi: 10.3389/fcvm.2022.1019945. eCollection 2022.
4
Acute Saddle Embolus With Thrombus in Transit: A Case Report and Review of the Literature.急性鞍状栓子合并移行血栓：一例病例报告及文献复习
Cureus. 2022 May 15;14(5):e25018. doi: 10.7759/cureus.25018. eCollection 2022 May.
5
Treatment and outcomes in patients with left ventricular thrombus - experiences from the Aga Khan University Hospital, Nairobi - Kenya.左心室血栓患者的治疗和结局 - 来自肯尼亚内罗毕 Aga Khan 大学医院的经验
Pan Afr Med J. 2021 Jul 23;39:212. doi: 10.11604/pamj.2021.39.212.28585. eCollection 2021.
6
Novel oral anticoagulants in intracardiac thrombosis resolution: a case series.新型口服抗凝剂用于心内血栓溶解：病例系列
Eur Heart J Case Rep. 2020 Aug 30;4(5):1-6. doi: 10.1093/ehjcr/ytaa181. eCollection 2020 Oct.
7
Off-label Use for Direct Oral Anticoagulants: Valvular Atrial Fibrillation, Heart Failure, Left Ventricular Thrombus, Superficial Vein Thrombosis, Pulmonary Hypertension-a Systematic Review.直接口服抗凝剂的超适应证应用：瓣膜性心房颤动、心力衰竭、左心室血栓、浅静脉血栓形成、肺动脉高压——系统评价。
Ann Pharmacother. 2021 Aug;55(8):995-1009. doi: 10.1177/1060028020970618. Epub 2020 Nov 4.
8
ST-Elevation Myocardial Infarction Presenting as Acute Limb Ischemia.表现为急性肢体缺血的ST段抬高型心肌梗死
Cureus. 2020 Sep 13;12(9):e10432. doi: 10.7759/cureus.10432.
9
Rationale and design of a prospective multi-center randomized trial of EARLY treatment by rivaroxaban versus warfarin in ST-segment elevation MYOcardial infarction with Left Ventricular Thrombus (EARLY-MYO-LVT trial).利伐沙班与华法林早期治疗ST段抬高型心肌梗死合并左心室血栓的前瞻性多中心随机试验（EARLY-MYO-LVT试验）的原理与设计
Ann Transl Med. 2020 Mar;8(6):392. doi: 10.21037/atm.2020.02.117.
10
Peripheral Embolization of Left Ventricular Thrombus Leading to Acute Bilateral Critical Limb Ischemia: A Rare Phenomenon.左心室血栓外周栓塞导致急性双侧严重肢体缺血：一种罕见现象。
Cardiol Res. 2020 Apr;11(2):134-137. doi: 10.14740/cr1030. Epub 2020 Mar 10.
2017年欧洲心脏病学会（ESC）ST段抬高型急性心肌梗死患者管理指南。
Rev Esp Cardiol (Engl Ed). 2017 Dec;70(12):1082. doi: 10.1016/j.rec.2017.11.010.
4
Utilization and prescribing patterns of direct oral anticoagulants.直接口服抗凝剂的使用情况及处方模式。
Int J Gen Med. 2017 Mar 10;10:87-94. doi: 10.2147/IJGM.S129235. eCollection 2017.
5
Simultaneous Left Ventricular and Deep Vein Thrombi Caused by Protein C Deficiency.蛋白C缺乏导致的同时性左心室和深静脉血栓形成
Case Rep Med. 2017;2017:4240959. doi: 10.1155/2017/4240959. Epub 2017 Jan 17.
6
Advances in oral anticoagulation therapy - What's in the pipeline?口服抗凝治疗的进展——未来有哪些可期？
Blood Rev. 2017 Jul;31(4):205-211. doi: 10.1016/j.blre.2017.02.002. Epub 2017 Feb 5.
7
Resolution of left ventricular postinfarction thrombi in patients undergoing percutaneous coronary intervention using rivaroxaban in addition to dual antiplatelet therapy.在接受经皮冠状动脉介入治疗的患者中，除双重抗血小板治疗外使用利伐沙班治疗左心室心肌梗死后血栓的溶解情况。
BMJ Case Rep. 2016 Oct 26;2016:bcr2016217843. doi: 10.1136/bcr-2016-217843.
8
DOACs - advances and limitations in real world.直接口服抗凝剂——现实世界中的进展与局限
Thromb J. 2016 Oct 4;14(Suppl 1):17. doi: 10.1186/s12959-016-0111-3. eCollection 2016.
9
Rates of major bleeding with rivaroxaban in real-world studies of nonvalvular atrial fibrillation patients: a meta-analysis.利伐沙班在非瓣膜性心房颤动患者真实世界研究中的大出血发生率：一项荟萃分析。
Curr Med Res Opin. 2016 Jun;32(6):1117-20. doi: 10.1185/03007995.2016.1161610. Epub 2016 Mar 16.
10
Dual antiplatelet agents and Rivaroxaban for massive intracoronary thrombus in STEMI.双联抗血小板药物与利伐沙班用于ST段抬高型心肌梗死的大面积冠状动脉血栓形成
Clin Case Rep. 2015 Nov;3(11):927-31. doi: 10.1002/ccr3.389. Epub 2015 Sep 22.